Keywords: correction, merck, co, januvia, april, issue, pharma

CORRECTION: Merck & Co's Januvia

Article | 07 May 2007

Print This

In the April 30 issue of Pharma Marketletter we reported that Merck & Co's antidiabetic agent Januvia (sitagliptin) is currently under US ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in